Patent: 10,519,227
✉ Email this page to a colleague
Summary for Patent: 10,519,227
Title: | Methods for reducing drug-induced liver injury |
Abstract: | The present disclosure provides methods of treating a patient with infliximab or alternative therapies to reduce the risk of developing, and/or severity of, an adverse drug reaction such as drug-induced liver injury. The methods include identifying patients at risk for developing DILI by determining the presence or absence of one or more HLA alleles in the patients. |
Inventor(s): | Srinivasan; Sundar (Corona Del Mar, CA), Chow; Christina (Seattle, WA) |
Assignee: | TEN PEAKS LLC (Corona Del Mar, CA) |
Application Number: | 16/406,695 |
Patent Claims: | see list of patent claims |
Details for Patent 10,519,227
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2038-05-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |